268 filings
Page 10 of 14
EFFECT
m2ue69x
23 Aug 17
Notice of effectiveness
12:00am
CORRESP
v9ggrjs2yop iu
21 Aug 17
Correspondence with SEC
12:00am
UPLOAD
71nkq1w42
14 Aug 17
Letter from SEC
12:00am
S-3
rgcd 4uf65vw8gglb
9 Aug 17
Shelf registration
12:00am
8-K
2r930dcj 6yz2e
8 Aug 17
Zafgen Reports Second Quarter 2017 Financial Results
12:00am
8-K
l4ffdljjff vl
23 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
pkvp aid0qa
9 May 17
Zafgen Reports First Quarter 2017 Financial Results
12:00am
8-K
6ehfn4
4 May 17
Zafgen Announces Positive Topline Phase 1 Data for ZGN-1061, a Second Generation MetAP2 Inhibitor
12:00am
S-8
4eexscvtsfracdgf234
10 Mar 17
Registration of securities for employees
12:00am
8-K
2rkdlsdfk4os
9 Mar 17
Zafgen Reports Fourth Quarter and Full Year 2016 Financial Results
12:00am
8-K
a936h5 rz
9 Nov 16
Zafgen Reports Third Quarter 2016 Financial Results
12:00am
8-K
5m5oih hfi03wgkve3m
4 Aug 16
Zafgen Reports Second Quarter 2016 Financial Results
12:00am
8-K
6vj 9cl77
19 Jul 16
Zafgen Refocuses Resources on Development of Differentiated Second-Generation MetAP2 Inhibitor ZGN-1061
12:00am
8-K
rxm7wvf791v3d y4
1 Jul 16
Departure of Directors or Certain Officers
12:00am